Watson Pharmaceutical (14 generic products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Watson Pharmaceutical (14 generic products) General Information

Description

Fourteen generic drug components. The fourteen products include five generic products marketed in the United States, eight abbreviated new drug applications and a generic product in late-stage development.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Par Pharmaceutical Companies
Primary Office
  • Clonshaugh Business and Technology Park
  • Coolock
  • Dublin E400
  • Ireland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Watson Pharmaceutical (14 generic products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Watson Pharmaceutical (14 generic products)‘s full profile, request access.

Request a free trial

Watson Pharmaceutical (14 generic products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Watson Pharmaceutical (14 generic products)‘s full profile, request access.

Request a free trial